Effect of ovarian steroids on vasopressin secretion.
In normally menstruating women plasma vasopressin concentrations vary with the stage of the cycle and are highest at the time of ovulation and lowest at the onset of menstruation. To determine whether this is the result of changes in the circulating concentrations of ovarian steroids, vasopressin concentrations were determined in six postmenopausal women given oestrogen and progestogen. An increase in plasma oestradiol concentrations to 299 +/- 97.8 pmol/l augmented vasopressin release. Administration of medroxyprogesterone did not influence vasopressin concentrations but when given in combination with oestrogen a fall was observed. Thus it appears that ovarian steroids can modulate vasopressin release.
D000818:Animals; D001127:Arginine Vasopressin / Q000097:blood*; D004958:Estradiol / Q000031:analogs & derivatives / Q000494:pharmacology; D004967:Estrogens / Q000502:physiology*; D004971:Estrus; D005260:Female; D006801:Humans; D008525:Medroxyprogesterone / Q000097:blood / Q000494:pharmacology; D008593:Menopause; D008875:Middle Aged; D011247:Pregnancy; D011374:Progesterone / Q000502:physiology*
D004967:Estrogens; D001127:Arginine Vasopressin; D011374:Progesterone; D004958:Estradiol; D008525:Medroxyprogesterone